Filing Details
- Accession Number:
- 0000927066-21-000077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-04 13:00:00
- Reporting Period:
- 2021-05-03
- Accepted Time:
- 2021-05-04 20:24:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
927066 | Davita Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640409 | Alyce Kathleen Waters | C/O Davita Inc. 2000 16Th Street Denver CO 80202 | Chief Legal & Pub. Affairs Off | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-03 | 28,164 | $75.70 | 97,694 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-05-03 | 18,296 | $116.53 | 79,398 | No | 4 | D | Direct | |
Common Stock | Disposition | 2021-05-03 | 4,578 | $116.53 | 74,820 | No | 4 | F | Direct | |
Common Stock | Disposition | 2021-05-03 | 5,290 | $118.36 | 69,530 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2021-05-03 | 28,164 | $0.00 | 28,164 | $75.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-05-06 | 2021-05-06 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2021.
- Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
- Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
- Represents the weighted average purchase price of $118.364. The range of prices for the purchase of these shares was $118.29 - $118.61 rounded to the nearest tenth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- Stock Appreciation Rights were granted on May 5, 2016, which vested 50% each on May 6, 2018 and May 6, 2019.